Back to Journals » OncoTargets and Therapy » Volume 9

Risk of brain metastasis reduced after erlotinib treatment in advanced pulmonary adenocarcinoma patients with sensitive EGFR mutation

Total article views   Abstract views HTML views PDF downloads Totals
3,816 Dovepress* 2,494 969+ 1,072 3,463
PubMed Central* 0 353 267 353
Totals 2,494 1,322 1,339 3,816
*Since 5 February 2016
+Since July 2016

View citations on PubMed Central and Google Scholar